Hainan Boao Research Hospital Secures Approval for China’s First Medical-Food Import for Rare Metabolic Disorders
Hainan Boao Research Hospital, operated by Shanghai’s Ruijin Hospital, has obtained provincial approval to import...
Sanofi’s Gene Therapy SAR446597 Secures FDA Fast Track for Geographic Atrophy
France-based Sanofi (NASDAQ: SNY) announced that its one-time intravitreal gene therapy SAR446597 has received FDA...
Tcelltech Secures USD 40 Million Series B Funding for TX-103 CAR-T Therapy Development
China-based Tcelltech Ltd., a developer of T-cell immunotherapies, has reportedly secured close to USD 40...
Hengrui Pharma and Kailera Announce Positive Phase III Results for HRS9531 in Obesity Treatment
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) and its US partner Kailera Therapeutics, Inc....
Haisco Pharma Receives FDA Approval for Clinical Trials of Autoimmune Drug HSK47388
China-based Haisco Pharmaceutical Group Co., Ltd (SHE: 002653) announced that it has received clinical trial...
Danaher’s Cytiva Collaborates with CorrectSequence on Gene Therapy LNP Delivery System
US-based science and tech services giant Danaher Corporation (NYSE: DHR) announced an ongoing collaboration between...
AstraZeneca’s Baxdrostat Meets Primary and Secondary Endpoints in Phase III BaxHTN Trial
UK-based AstraZeneca (AZ, NASDAQ: AZN) announced that baxdrostat has achieved both primary and secondary endpoints in the...
Shanghai Sanyou Medical Receives NMPA Marketing License for JAZZ Spinal Fixation System
Shanghai Sanyou Medical Co., Ltd (SHA: 688085) announced that it has received the marketing license...
NMPA Updates Reference Drugs for GQCE Evaluation: 42 New Additions and 6 Removals
China’s National Medical Products Administration (NMPA) has released the 94th batch of reference drugs for...
BD Merges Biosciences & Diagnostic Solutions with Waters Corporation in USD 17.5 Billion Deal
US major Becton, Dickinson and Co., (BD) is set to merge its Biosciences & Diagnostic...
Sino Biopharmaceutical Acquires Majority Stake in LaNova Medicines for USD 950.92 Million
China-based Sino Biopharmaceutical Ltd (HKG: 1177) announced the acquisition of a 95.09% stake in Shanghai-based...
Vigonvita’s Simenafil Receives NMPA Approval for Erectile Dysfunction Treatment
Suzhou-based Vigonvita Life Sciences Co., Ltd., announced that it has received marketing approval from the...
Xgene Licenses Novel Non-Opioid Analgesic XG005 to NeuroGen for Greater China Development
Shanghai-based Xgene Pharmaceutical Inc. has entered into a licensing agreement withNeuroGen Pharma, a neurology care...
Otsuka to Acquire Cantargia’s IL-1RAP Monoclonal Antibody CAN10 for Autoimmune Diseases
Japan-based drug maker Otsuka (OTCMKTS: OTSKY) is set to acquire from Swedish biotech Cantargia AB...
Huadong Medicine Receives FDA Approval for Clinical Trials of Innovative ADC HDM2020
China-based Huadong Medicine Co., Ltd (SHE: 000963) announced that it has received clinical trial approval...
Ningbo Health Gene and Biofast Biotech Partner to Advance Genetic Testing for Hereditary Diseases
Chinese firms Ningbo Health Gene Technologies Co., Ltd. and Biofast Biotechnology Co., Ltd. announced late...
Boehringer Ingelheim Licenses Spevigo to LEO Pharma for Global Dermatology Expansion
German pharmaceutical giant Boehringer Ingelheim (BI) this week announced a licensing agreement with Denmark-based dermatology...
Peijia Medical Completes First Patient Implantation for MonarQ TTVR System in Global Clinical Study
China-based Peijia Medical Ltd (HKG: 9996) announced the successful completion of the first patient implantation...
Golden Age Health Secures Exclusive Rights to Innostellar’s Gene Therapy LX-101 in China
Singapore-based Golden Age Health, a specialty pharmaceutical company focused on rare and specialty diseases, has...
Merck Initiates EXPrESSIVE Phase III Trial for Once-Monthly HIV PrEP Drug MK-8527
Merck, Sharp & Dohme Inc., (MSD; NYSE: MRK) announced the initiation of the EXPrESSIVE Phase...